UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

The Journal of urology, 2008-07, Vol.180 (1), p.47-54

2008

Link zum Volltext

Verfügbarkeit prüfen

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Value in health, 2010-03, Vol.13 (2), p.251-257

2010

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of urology, 2009-04, Vol.181 (4), p.1764-1772

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

Urology (Ridgewood, N.J.), 2010, Vol.75 (1), p.62-68

2010

Link zum Volltext

Verfügbarkeit prüfen

A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS

The Journal of urology, 2005-08, Vol.174 (2), p.604-607

2005

Link zum Volltext

Verfügbarkeit prüfen

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Urology (Ridgewood, N.J.), 2008-03, Vol.71 (3), p.449-454

2008

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Current urology reports, 2012-10, Vol.13 (5), p.327-334

2012

Link zum Volltext

Verfügbarkeit prüfen

Overactive bladder in the elderly : A guide to pharmacological management

Drugs & aging, 2005-01, Vol.22 (12), p.1013-1028

STASKIN, David R

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Urology (Ridgewood, N.J.), 2010-05, Vol.75 (5), p.1144-1148

2010

Link zum Volltext

Verfügbarkeit prüfen

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

BJU international, 2011-02, Vol.107 (4), p.612-620

2011

Link zum Volltext

Verfügbarkeit prüfen

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, Vol.32 (10), p.707-714

2012

Link zum Volltext

Verfügbarkeit prüfen

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

Mayo Clinic proceedings, 2001-04, Vol.76 (4), p.358-363

2001

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms

The Journal of urology, 2012-05, Vol.187 (5), p.1721-1726

2012

Link zum Volltext

Verfügbarkeit prüfen

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

BJU international, 2006-06, Vol.97 (6), p.1256-1261

2006

Link zum Volltext

Verfügbarkeit prüfen

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?: B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler J Urol 2009; 181: 2209–2213

The Journal of urology, 2009-12, Vol.182 (6), p.2981-2982

2009

Link zum Volltext

Verfügbarkeit prüfen

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

Neurourology and urodynamics, 2011-09, Vol.30 (7), p.1214-1219

2011

Link zum Volltext

Verfügbarkeit prüfen

Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder. Eur Urol 2008;54:740–64

European urology, 2009-05, Vol.55 (5), p.e84-e85

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

Current urology reports, 2004-12, Vol.5 (6), p.423-426

2004

Link zum Volltext

Verfügbarkeit prüfen

Overview consensus statement

Urology (Ridgewood, N.J.), 2002-11, Vol.60 (5), p.1-6

2002

Link zum Volltext

Verfügbarkeit prüfen

Antimuscarinic therapy in men with bladder outlet obstruction

Current urology reports, 2006-11, Vol.7 (6), p.437-439

2006

Link zum Volltext

Verfügbarkeit prüfen

Definition and epidemiology of overactive bladder

Urology (Ridgewood, N.J.), 2002-11, Vol.60 (5), p.7-12

2002

Link zum Volltext

Verfügbarkeit prüfen

Pathophysiology: the varieties of bladder overactivity

Urology (Ridgewood, N.J.), 2002-11, Vol.60 (5), p.22-26

Mostwin, Jacek L

2002

Link zum Volltext

Verfügbarkeit prüfen

Nocturnal polyuria versus overactive bladder in nocturia

Urology (Ridgewood, N.J.), 2002-11, Vol.60 (5), p.28-32

2002

Link zum Volltext

Verfügbarkeit prüfen

Overactive bladder in men: special considerations for evaluation and management

Urology (Ridgewood, N.J.), 2002-11, Vol.60 (5), p.56-62

2002

Link zum Volltext

Verfügbarkeit prüfen

Urinary Incontinence: Steps to Evaluation, Diagnosis, and Treatment

The Nurse practitioner, 1997-02, Vol.22 (2), p.21-45

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Female
(33)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Urology & Nephrology
(22)
Middle Aged
(20)
Aged
(18)
Adult
(13)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Urinary Bladder, Overactive - Drug Therapy
(13)
Muscarinic Antagonists - Therapeutic Use
(12)
Nephrology. Urinary Tract Diseases
(12)
Treatment Outcome
(12)
Urinary System Involvement In Other Diseases. Miscellaneous
(12)
Urinary Tract. Prostate Gland
(12)
Double-Blind Method
(11)
Urology
(10)
Muscarinic Antagonists - Adverse Effects
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Urinary Retention and Post-Void Residual Urine in Men: Separating Truth From Tradition

Extended-Release Trospium Chloride Improves Quality of Life in Overactive Bladder

Efficacy and Safety of Oxybutynin Chloride Topical Gel for Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled, Multicenter Study

Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder

A VALIDATED PATIENT REPORTED MEASURE OF URINARY URGENCY SEVERITY IN OVERACTIVE BLADDER FOR USE IN CLINICAL TRIALS

Trospium 60 mg Once Daily (QD) for Overactive Bladder Syndrome: Results from a Placebo-Controlled Interventional Study

Percutaneous Tibial Nerve Stimulation: A Clinically and Cost Effective Addition to the Overactive Bladder Algorithm of Care

Overactive bladder in the elderly : A guide to pharmacological management

Efficacy and Safety of Tolterodine Extended Release and Dutasteride in Male Overactive Bladder Patients With Prostates >30 Grams

Trospium chloride once‐daily extended release is efficacious and tolerated in elderly subjects (aged ≥75 years) with overactive bladder syndrome

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study

The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms

Short‐ and long‐term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence

Re: Benign Prostatic Obstruction and Parkinson's Disease—Should Transurethral Resection of the Prostate be Avoided?: B. Roth, U. E. Studer, C. J. Fowler and T. M. Kessler J Urol 2009; 181: 2209–2213

Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms

Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder. Eur Urol 2008;54:740–64

Effect of trospium chloride on somnolence and sleepiness in patients with overactive bladder

Overview consensus statement

Antimuscarinic therapy in men with bladder outlet obstruction

Definition and epidemiology of overactive bladder

Pathophysiology: the varieties of bladder overactivity

Nocturnal polyuria versus overactive bladder in nocturia

Overactive bladder in men: special considerations for evaluation and management

Urinary Incontinence: Steps to Evaluation, Diagnosis, and Treatment

Aktive Filter

Suchergebnisse filtern